Kaneka increases contract manufacturing capacity at Eurogentec S. A.

Belgiums Eurogentec S.A., a 100 % affiliate of Kaneka, which handles outsourced production of biopharmaceuticals, will increase its GMP manufacturing facility and include a 2,200 L bioreactor, 4x the present capacity.

Kaneka news release, May 9, 2017

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny